艾迪注射液在肺癌治疗中的研究进展  

The research progress of Addie Injection in the lung cancer treatment

作　　者：席青[1] 王建清[1] 常小红[1] 

机构地区：[1]延安大学附属医院呼吸科,陕西延安716000

出　　处：《中国医药导报》2014年第4期163-165,共3页China Medical Herald

摘　　要：肺癌是严重威胁人类健康的恶性肿瘤之一,目前多采用化疗治疗。艾迪注射液由人参、黄芪、刺五加、去甲斑蝥素四种中药成分组合而成,具有抑制肿瘤细胞增殖、血管生成,减轻放疗所致的胃肠道反应,减轻骨髓抑制,增强机体免疫功能,改善生活质量等作用,在临床上应用广泛,目前治疗肺癌多联合化疗,减轻化疗的副作用。Lung cancer is one of the malignant tumor which threaten the human＇s health seriously,we usually use chemnotherapy medicine to cure it at present.Addie Injection is made up by four traditional Chinese medicine：Ginseng,Astragalus,Acanthopanax setaceous and Norcanthridin,which can restrain inhibit tumor cell proliferation,angiogenesis and reduce the gastrointestinal reaction caused by chemotherapy and myelosuppression,because it can enhance the human＇s immune function and improve the quality of life and other functions,it is widely used in clinic nowadays.Now the treatment of lung cancer usually uses traditional Chinese medicine combining chemotherapy to reduce the side effects of chemotherapy.

关 键 词：艾迪注射液 肺癌 化疗 

分 类 号：R725.7[医药卫生—儿科]